top of page

Canurta Journal
A collection of news, scientific papers and impact across industry, academia and events.


Aug 21, 2024
FDA Drug Approvals in 2023: Insights into Trends and Molecule Types
In 2023, the U.S. Food and Drug Administration (FDA) approved 55 new drugs, marking a significant year in pharmaceutical advancements....


Jul 31, 2024
Canurta Therapeutics Secures First US Patent for Novel Bioactive Polyphenol Extraction Process
July 31, 2024 – Toronto, Canada: Canurta Therapeutics is pleased to announce the granting of its first US patent for the company’s...


Jul 17, 2024
AI: Transforming the Future of Nutraceuticals
The advent of Artificial Intelligence (AI) is revolutionizing the nutraceutical industry, transitioning from traditional development...


May 24, 2024
Reflecting on the ALS Drug Development Summit in Boston
This week, I had the opportunity to attend the ALS Drug Development Summit in Boston, an event that brought together the brightest minds...


Feb 8, 2024
Canurta Inc. Unveils Strategic Reorganization & Rebranding: Introducing Canurta Therapeutics and Canurta Naturals
We are pleased to announce a significant transformation in our corporate structure and brand architecture. The organization will now have...


Mar 13, 2023
Canurta Receives Funding from the Government of Canada for Respiratory Disease Therapeutics
The Company has received $150,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC...


Mar 9, 2023
Interview with The Ontario Centre of Innovation
We're excited to announce that our CEO, Akeem Gardner, was recently interviewed by the Ontario Centre of Innovation (OCI) about the...


Feb 22, 2023
Responsible & Resilient: Canurta in your Community
Letter from our CEO I am writing to you today as the CEO of our company in the biotech and agricultural industries. I understand that...

Sep 27, 2021
Canurta’s White Paper: Grounds for Further Investigation into Rare Hemp Polyphenols
Given the scarcity of Canurta’s novel molecules, they have never been formally assayed in animal or human models. Canurta has committed...
bottom of page